LSTM Home > LSTM Research > LSTM Online Archive

Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma

Challenger, Elizabeth, Penchala, Sujan Dilly, Hale, Colin, Fitzgerald, Richard, Walker, Lauren, Reynolds, Helen, Chiong, Justin, Fletcher, Tom, Khoo, Saye and Else, Laura (2023) 'Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma'. Journal of Pharmaceutical and Biomedical Analysis, Vol 233, e115436.

1-s2.0-S0731708523002054-main.pdf - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview


Favipiravir (FVP) is a broad-spectrum antiviral that selectively inhibits viral RNA-dependent RNA polymerase, first trialled for the treatment of influenza infection. It has been shown to be effective against a number of RNA virus families including arenaviruses, flaviviruses and enteroviruses. Most recently, FVP has been investigated as a potential therapeutic for severe acute respiratory syndrome coronavirus 2 infection. A liquid chromatography tandem mass spectrometry method for the quantification of FVP in human plasma has been developed and validated for use in clinical trials investigating favipiravir as treatment for coronavirus disease-2019. Samples were extracted by protein precipitation using acetonitrile, using C, N- Favipiravir as internal standard. Elution was performed on a Synergi Polar-RP 150 × 2.1 mm 4 µm column using a gradient mobile phase programme consisting of 0.2% formic acid in water and 0.2% formic acid in methanol. The assay was validated over the range 500-50,000 ng/mL; this method was found to be precise and accurate and recovery of FVP from the matrix was high. Stability experiments confirmed and expanded on the known stability of FVP, including under heat treatment and for a period of 10 months at - 80 °C.

Item Type: Article
Subjects: WC Communicable Diseases > Virus Diseases > Viral Respiratory Tract Infections. Respirovirus Infections > WC 506 COVID-19
Faculty: Department: Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):
SWORD Depositor: JISC Pubrouter
Depositing User: JISC Pubrouter
Date Deposited: 22 May 2023 09:24
Last Modified: 22 May 2023 10:00


View details

Actions (login required)

Edit Item Edit Item